Time point | Control group | OVX group | t value | P value |
---|---|---|---|---|
Emax | ||||
Baseline | 1.51 ± 0.19 | 1.51 ± 0.06 | 0.000 | 1.000 |
Week 3 | 1.53 ± 0.34 | 1.35 ± 0.14 | 1.053 | 0.323 |
Week 6 | 1.69 ± 0.19 | 1.30 ± 0.09 | 4.182 | 0.003# |
Week 9 | 1.58 ± 0.09 | 1.26 ± 0.16 | 3.971 | 0.004# |
Week 12 | 1.39 ± 0.16 | 1.35 ± 0.16 | 0.313 | 0.762 |
Ktrans (min−1) | ||||
Baseline | 0.29 ± 0.06 | 0.34 ± 0.03 | −1.653 | 0.137 |
Week 3 | 0.28 ± 0.08 | 0.18 ± 0.03* | 2.646 | 0.029# |
Week 6 | 0.29 ± 0.07 | 0.20 ± 0.02* | 2.691 | 0.027# |
Week 9 | 0.26 ± 0.08 | 0.18 ± 0.01* | 2.462 | 0.039# |
Week 12 | 0.25 ± 0.06 | 0.16 ± 0.02* | 2.724 | 0.041# |
Ve (mL/100 mL) | ||||
Baseline | 0.36 ± 0.08 | 0.38 ± 0.09 | −0.376 | 0.716 |
Week 3 | 0.41 ± 0.18 | 0.25 ± 0.07 | 1.825 | 0.105 |
Week 6 | 0.37 ± 0.08 | 0.29 ± 0.05 | 1.825 | 0.105 |
Week 9 | 0.33 ± 0.08 | 0.22 ± 0.05* | 2.600 | 0.032# |
Week 12 | 0.27 ± 0.05 | 0.25 ± 0.06 | 0.556 | 0.594 |
Kep (min−1) | ||||
Baseline | 0.79 ± 0.08 | 0.94 ± 0.18 | −1.667 | 0.134 |
Week 3 | 0.70 ± 0.29 | 0.84 ± 0.22 | −0.868 | 0.410 |
Week 6 | 0.77 ± 0.15 | 0.71 ± 0.18 | 0.560 | 0.591 |
Week 9 | 0.80 ± 0.23 | 0.82 ± 0.24 | −0.194 | 0.851 |
Week 12 | 0.86 ± 0.16 | 0.65 ± 0.15 | 2.224 | 0.057 |